egypt vaccines market

Egypt Vaccines Market: Segmentation by Disease Indication (Pneumococcal Disease, Influenza, Meningococcal Disease, Polio, Rotavirus, Hepatitis, Dengue, Herpes Zoster, Others), Route of Administration (Oral, Injectables, Others), and End-User (Paediatric Population and Adult Population) - Growth, Trends, And Forecasts (2019 to 2028)

  • Published Date: 2022-12-13
  • Report ID: 141590
  • Pages: 200
  • Format: prudent report format

Egypts Vaccine market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The vaccine market is usually different from the pharmaceutical market and other products. Although it is a small market comparatively, it has a tremendous growth rate. Vaccines for COVID-19 are critical tools for helping to bring the pandemic under control when combined with effective testing, treatment, and existing prevention measures. Vaccinating the world against this disease is the largest vaccine procurement and supply operation in history.

Countries including Egypt, Iraq, and others use the procurement services of the UNICEF Supply Division for a number of their routine vaccines. Iran and Egypt locally produce a few traditional vaccines.



Market Drivers

The ongoing COVID-19 pandemic has once again brought the vaccine market into focus and it is expected to see a rise in the country.

As per recent analysis, preventive vaccine market in the Middle East and Africa are deemed to have decent growth opportunities in the forecast period. This can be attributed to certain drivers like increased funding for vaccine development from the government, huge investments by multinational companies into the research and development departments of preventive vaccines, technology-facilitated new innovations, and initiatives by some non-governmental organizations.

However, the market also has some restraints such as high capital expenditure and stringent policies by the government.

 


1. Vaccine Market Overview..........................
A. Market Size
2. Market Growth Drivers.
A. New Pandemic Covid-19
B. Government Funding for Vaccine Development
C. Increased MNC Expenditure into R&D
3. Major Types of Vaccines
I. Live, Attenuated Vaccines
II. Inactivated Vaccines
III. Toxoid Vaccines
IV. Subunit Vaccines
V. Conjugate Vaccines
VI. DNA Vaccines
VII. Recombinant Vector Vaccines
4. Vaccines Market Segmentation..................
A. Disease Indication
I. Pneumococcal Disease
II. Influenza
III. Meningococcal Disease
IV. Polio
V. Rotavirus
VI. Hepatitis
VII. Dengue
VIII. Herpes
IX. Zoster
X. Others
B. Route of Administration
I. Oral
II. Injectables
III. Others
C. End-User
I. Paediatric Population
II. Adult Population
5. Major Vaccines Market Share..
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. VASCERA overview, Product & Services, Strategies & Financials
B. AstraZeneca Company overview, Product & Services, Strategies & Financials
C. Sanofi Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape.
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth.
A. New Trends and Development of Vaccines market
B. Future Opportunities
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.